Blood Screening Typing Market

Blood Screening Typing Market - Global Industry Size & Growth Analysis 2019-2031

Global Blood Screening Typing is segmented by Application (Healthcare, Blood Donation, Diagnostics, Medical Research, Transfusion), Type (Genetic Testing, PCR, Serological, Antibody Screening, Blood Typing) and Geography(North America, LATAM, West Europe, Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA)

Pricing
5400
3400
1800

INDUSTRY OVERVIEW

The Blood Screening Typing is Growing at 22% and is expected to reach 8Billion by 2031.  Below mentioned are some of the dynamics shaping the Blood Screening Typing .

Blood Screening Typing Market Size in (USD Billion) CAGR Growth Rate 22%

Study Period 2019-2031
Market Size (2023): 3Billion
Market Size (2031): 8Billion
CAGR (2023 - 2031): 22%
Fastest Growing Region Asia-Pacific
Dominating Region North America
www.www.htfmarketinsights.com

Blood screening typing is a test that determines a person’s blood type. The test is essential if need a blood transfusion or are planning to donate blood. Not all blood types are compatible, so it’s important to know blood group. Receiving blood that’s incompatible with blood type could trigger a dangerous immune response. Blood screening typing is done prior to a blood transfusion or when classifying a person’s blood for donation. Blood typing is a fast and easy way to ensure that receive the right kind of blood during surgery or after an injury. Blood screening typing is especially important for pregnant women.
Need More Details on Market Players and Competitors?
DOWNLOAD Sample Report

Market Drivers:
The key drivers in the market include technological advancements, increasing demand by consumers for innovative products, and government-friendly policies. Our research company combines industry reports with expert interviews and market analysis tools to identify and quantify drivers such as these. We review the current trends and gather data from leading industry publications and market research firms to decipher exactly how these and other factors are encouraging or dampening market growth.
  • Increasing Need For Blood Transfusion In Critical Patients

Market Restraints:

Some of the restraints to market growth may include regulatory challenges, high production costs, and disruptions in the supply chain. Our sources for these limitations include the regulation filings, industry surveys, and direct contributions from active participants within this marketplace. Tracking policy updates and economic reports further helps us to determine what kind of effect these factors have on the industry.
  • Regulatory Approval

Trends in the Market:

Among the trending ones are sustainability, digital transformation, and increasing importance of data analytics. Our research company is tracking these trends through the use of trend analysis tools, social media sentiment analysis, and industry benchmarking studies. Insights in emerging market preferences and technological advancements also come from surveys and focus groups.
  • Healthcare
Market Opportunities:

These include emerging markets, innovation in product development, and strategic partnerships. We identify these opportunities by performing market segmentation analysis, competitive landscape assessment, and investment trend evaluation. The data is collected based on industry reports, financial performance analysis for major players, and forecasting models for identifying future growth areas.

  • Increasing Healthcare Expenditure
Check Out Prices
Get Price


Regulation Shaping the Healthcare Industry

The healthcare industry is significantly influenced by a complex framework of regulations designed to ensure patient safety, efficacy of treatments, and the overall quality of care. Key regulatory areas include drug approval processes, medical device standards, and healthcare data protection. These regulations aim to maintain high standards for clinical practices and safeguard public health.

Major Regulatory Bodies Worldwide

1. U.S. Food and Drug Administration (FDA): In the United States, the FDA is a pivotal regulatory authority overseeing the approval and monitoring of pharmaceuticals, medical devices, and biologics. The FDA sets stringent standards for product safety and efficacy, which significantly impacts market entry and ongoing compliance for healthcare companies.
2. European Medicines Agency (EMA): The EMA plays a crucial role in the European Union, evaluating and supervising medicinal products. It provides centralized approval for drugs and ensures that products meet rigorous safety and efficacy standards across member states.
3. Health Canada: This agency regulates pharmaceuticals and medical devices in Canada, ensuring that products are safe, effective, and of high quality. Health Canada's regulations are aligned with international standards but tailored to meet national health needs.
4. World Health Organization (WHO): While not a regulatory body in the traditional sense, the WHO sets international health standards and provides guidelines that influence national regulatory frameworks. It plays a key role in global health policy and emergency response.
5. National Medical Products Administration (NMPA): In China, the NMPA regulates the approval and supervision of drugs and medical devices, with an increasing focus on aligning with global standards and facilitating market access.
Request for Customization
Get Customization


SWOT Analysis in the Healthcare Industry

SWOT analysis in the healthcare industry involves a structured assessment of Strengths, Weaknesses, Opportunities, and Threats to identify strategic advantages and areas for improvement.

•    Strengths: Evaluates internal factors such as advanced technology, skilled personnel, and strong brand reputation. For example, a hospital with cutting-edge medical equipment and specialized staff is considered to have a strong competitive edge.
•    Weaknesses: Identifies internal limitations like outdated facilities, regulatory compliance issues, or high operational costs. Weaknesses could include inefficient processes or lack of innovation.
•    Opportunities: Assesses external factors that could drive growth, such as emerging medical technologies, expanding markets, or favorable government policies. Opportunities might involve partnerships or new service lines.
•    Threats: Examines external challenges such as increasing competition, changing regulations, or economic downturns. Threats might include new entrants with disruptive technologies or stricter regulatory requirements.

Market Segmentation

Segmentation by Type


  • Genetic Testing
  • PCR
  • Serological
  • Antibody Screening

Blood Screening Typing Market Segmentation by Type

www.htfmarketinsights.com


Segmentation by Application


  • Healthcare
  • Blood Donation
  • Diagnostics
  • Medical Research
  • Transfusion

Blood Screening Typing Market Segmentation by Application

www.htfmarketinsights.com

Regional Outlook

The North America currently holds a significant share of the market, primarily due to several key factors: increasing consumption rates, a burgeoning population, and robust economic momentum. These elements collectively drive demand, positioning this region as a leader in the market. On the other hand, Asia-Pacific is rapidly emerging as the fastest-growing area within the industry. This remarkable growth can be attributed to swift infrastructure development, the expansion of various industrial sectors, and a marked increase in consumer demand. These dynamics make this region a crucial player in shaping future market growth. In our report, we cover a comprehensive analysis of the regions and countries, including 

Regions
  • North America
  • LATAM
  • West Europe
  • Central & Eastern Europe
  • Northern Europe
  • Southern Europe
  • East Asia
  • Southeast Asia
  • South Asia
  • Central Asia
  • Oceania
  • MEA
Fastest Growing Region
Asia-Pacific
Blood Screening Typing Market to see Asia-Pacific as Biggest Region
Dominating Region
North America
Blood Screening Typing Market to see North America as Biggest Region



The company consistently allocates significant resources to expand its research capabilities, develop new medical technologies, and enhance its pharmaceutical portfolio. Johnson & Johnson's investments in R&D, coupled with strategic acquisitions and partnerships, reinforce its position as a major contributor to advancements in healthcare. This focus on innovation and market expansion underscores the critical importance of the North American region in the global healthcare landscape.

  • Agena Bioscience
  • Inc. (United States)
  • Beckman Coulter. (United States)
  • Bio-Rad Laboratories
  • Inc. (United States)
  • DAY MEDICAL SA. (Switzerland)
  • Grifols
  • S.A. (Spain)
  • Immucor
  • Inc. (United States)
  • Merck KGaA. (Germany)
  • Quotient
  • Ltd. (Switzerland)
  • Abbott Laboratories
  • Inc. (United States)

Blood Screening Typing Market Segmentation by Players

www.htfmarketinsights.com

Primary and Secondary Research

Primary research involves the collection of original data directly from sources in the healthcare industry. Approaches include the survey of health professionals, interviews with patients, focus groups, and clinical trials. This gives an overview of the current practice, the needs of the patient, and the interest in emerging trends. Firsthand information on the efficacy of new treatments, an assessment of market demand, and insight into changes in regulation can be sought only with primary research.
Secondary Research: This is the investigation of existing information from a variety of sources, which may include industry reports, academic journals, government publications, and market research studies. Alfred secondary research empowers them to understand trends within industries, historical data, and competitive landscapes. It gives a wide view of the market dynamics and validates findings obtained from primary research. By combining both primary and secondary together, health organizations will be empowered to develop comprehensive strategies and make informed decisions based on a strong foundation built on data.

Report Infographics

Report Features

Details

Base Year

2023

Based Year Market Size (2023)

3Billion

Historical Period

2019 to 2023

CAGR (2023 to 2031)

22%

Forecast Period

2023 to 2031

Forecasted Period Market Size (2031)

8Billion

Scope of the Report

Genetic Testing, PCR, Serological, Antibody Screening, Healthcare, Blood Donation, Diagnostics, Medical Research, Transfusion. Sales Channel

Regions Covered

North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA

Companies Covered

Agena Bioscience, Inc. (United States), Beckman Coulter. (United States), Bio-Rad Laboratories, Inc. (United States), DAY MEDICAL SA. (Switzerland), Grifols, S.A. (Spain), Immucor, Inc. (United States), Merck KGaA. (Germany), Quotient, Ltd. (Switzerland), Abbott Laboratories, Inc. (United States)

Customization Scope

15% Free Customization (For EG)

Delivery Format

PDF and Excel through Email

Blood Screening Typing - Table of Contents

Chapter 1: Market Preface
  • 1.1 Global Blood Screening Typing Market Landscape
  • 1.2 Scope of the Study
  • 1.3 Relevant Findings & Stakeholder Advantages

Chapter 2: Strategic Overview
  • 2.1 Global Blood Screening Typing Market Outlook
  • 2.2 Total Addressable Market versus Serviceable Market
  • 2.3 Market Rivalry Projection

Chapter 3 : Global Blood Screening Typing Market Business Environment & Changing Dynamics
  • 3.1 Growth Drivers
    • 3.1.1 Increasing need for Blood Transfusion in Critical Patients
  • 3.2 Available Opportunities
    • 3.2.1 Increasing Healthcare Expenditure
  • 3.3 Influencing Trends
    • 3.3.1 Healthcare
    • 3.3.2 blood tests
  • 3.4 Challenges
    • 3.4.1 Regulatory approval
    • 3.4.2 market competition
  • 3.5 Regional Dynamics

Need only Qualitative Analysis? Get Prices
Sectional Purchase
Chapter 4 : Global Blood Screening Typing Industry Factors Assessment
  • 4.1 Current Scenario
  • 4.2 PEST Analysis
  • 4.3 Business Environment - PORTER 5-Forces Analysis
    • 4.3.1 Supplier Leverage
    • 4.3.2 Bargaining Power of Buyers
    • 4.3.3 Threat of Substitutes
    • 4.3.4 Threat from New Entrant
    • 4.3.5 Market Competition Level
  • 4.4 Roadmap of Blood Screening Typing Market
  • 4.5 Impact of Macro-Economic Factors
  • 4.6 Market Entry Strategies
  • 4.7 Political and Regulatory Landscape
  • 4.8 Supply Chain Analysis


Chapter 5: Blood Screening Typing : Competition Benchmarking & Performance Evaluation
  • 5.1 Global Blood Screening Typing Market Concentration Ratio
    • 5.1.1 CR4, CR8 and HH Index
    • 5.1.2 % Market Share - Top 3
    • 5.1.3 Market Holding by Top 5
  • 5.2 Market Position of Manufacturers by Blood Screening Typing Revenue 2023
  • 5.3 Global Blood Screening Typing Sales Volume by Manufacturers (2023)
  • 5.4 BCG Matrix
  • 5.4 Market Entropy
  • 5.5 FPNV Positioning Matrix
  • 5.6 Heat Map Analysis
Chapter 6: Global Blood Screening Typing Market: Company Profiles
  • 6.1 Agena Bioscience
    • 6.1.1 Agena Bioscience Company Overview
    • 6.1.2 Agena Bioscience Product/Service Portfolio & Specifications
    • 6.1.3 Agena Bioscience Key Financial Metrics
    • 6.1.4 Agena Bioscience SWOT Analysis
    • 6.1.5 Agena Bioscience Development Activities
  • 6.2 Inc. (United States)
  • 6.3 Beckman Coulter. (United States)
  • 6.4 Bio-Rad Laboratories
  • 6.5 Inc. (United States)
  • 6.6 DAY MEDICAL SA. (Switzerland)
  • 6.7 Grifols
  • 6.8 S.A. (Spain)
  • 6.9 Immucor
  • 6.10 Inc. (United States)
  • 6.11 Merck KGaA. (Germany)
  • 6.12 Quotient
  • 6.13 Ltd. (Switzerland)
  • 6.14 Abbott Laboratories
  • 6.15 Inc. (United States)
  • 6.16 F. Hoffmann-La Roche Ltd. (Switzerland)

To View a Complete List of Players? Inquiry Now
Sectional Purchase

Chapter 7 : Global Blood Screening Typing by Type & Application (2019-2031)
  • 7.1 Global Blood Screening Typing Market Revenue Analysis (USD Million) by Type (2019-2023)
    • 7.1.1 Genetic Testing
    • 7.1.2 PCR
    • 7.1.3 Serological
    • 7.1.4 Antibody Screening
    • 7.1.5 Blood Typing
  • 7.2 Global Blood Screening Typing Market Revenue Analysis (USD Million) by Application (2019-2023)
    • 7.2.1 Healthcare
    • 7.2.2 Blood Donation
    • 7.2.3 Diagnostics
    • 7.2.4 Medical Research
    • 7.2.5 Transfusion
  • 7.3 Global Blood Screening Typing Market Revenue Analysis (USD Million) by Type (2023-2031)
  • 7.4 Global Blood Screening Typing Market Revenue Analysis (USD Million) by Application (2023-2031)

Chapter 8 : North America Blood Screening Typing Market Breakdown by Country, Type & Application
  • 8.1 North America Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 8.1.1 United States
    • 8.1.2 Canada
  • 8.2 North America Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 8.2.1 Genetic Testing
    • 8.2.2 PCR
    • 8.2.3 Serological
    • 8.2.4 Antibody Screening
    • 8.2.5 Blood Typing
  • 8.3 North America Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 8.3.1 Healthcare
    • 8.3.2 Blood Donation
    • 8.3.3 Diagnostics
    • 8.3.4 Medical Research
    • 8.3.5 Transfusion
  • 8.4 North America Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 8.5 North America Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 8.6 North America Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Looking for Section Purchase? Get Quote Now
Sectional Purchase

Chapter 9 : LATAM Blood Screening Typing Market Breakdown by Country, Type & Application
  • 9.1 LATAM Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 9.1.1 Brazil
    • 9.1.2 Argentina
    • 9.1.3 Chile
    • 9.1.4 Mexico
    • 9.1.5 Rest of LATAM
  • 9.2 LATAM Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 9.2.1 Genetic Testing
    • 9.2.2 PCR
    • 9.2.3 Serological
    • 9.2.4 Antibody Screening
    • 9.2.5 Blood Typing
  • 9.3 LATAM Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 9.3.1 Healthcare
    • 9.3.2 Blood Donation
    • 9.3.3 Diagnostics
    • 9.3.4 Medical Research
    • 9.3.5 Transfusion
  • 9.4 LATAM Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 9.5 LATAM Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 9.6 LATAM Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 10 : West Europe Blood Screening Typing Market Breakdown by Country, Type & Application
  • 10.1 West Europe Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 10.1.1 Germany
    • 10.1.2 France
    • 10.1.3 Benelux
    • 10.1.4 Switzerland
    • 10.1.5 Rest of West Europe
  • 10.2 West Europe Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 10.2.1 Genetic Testing
    • 10.2.2 PCR
    • 10.2.3 Serological
    • 10.2.4 Antibody Screening
    • 10.2.5 Blood Typing
  • 10.3 West Europe Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 10.3.1 Healthcare
    • 10.3.2 Blood Donation
    • 10.3.3 Diagnostics
    • 10.3.4 Medical Research
    • 10.3.5 Transfusion
  • 10.4 West Europe Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 10.5 West Europe Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 10.6 West Europe Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 11 : Central & Eastern Europe Blood Screening Typing Market Breakdown by Country, Type & Application
  • 11.1 Central & Eastern Europe Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 11.1.1 Bulgaria
    • 11.1.2 Poland
    • 11.1.3 Hungary
    • 11.1.4 Romania
    • 11.1.5 Rest of CEE
  • 11.2 Central & Eastern Europe Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 11.2.1 Genetic Testing
    • 11.2.2 PCR
    • 11.2.3 Serological
    • 11.2.4 Antibody Screening
    • 11.2.5 Blood Typing
  • 11.3 Central & Eastern Europe Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 11.3.1 Healthcare
    • 11.3.2 Blood Donation
    • 11.3.3 Diagnostics
    • 11.3.4 Medical Research
    • 11.3.5 Transfusion
  • 11.4 Central & Eastern Europe Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 11.5 Central & Eastern Europe Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 11.6 Central & Eastern Europe Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 12 : Northern Europe Blood Screening Typing Market Breakdown by Country, Type & Application
  • 12.1 Northern Europe Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 12.1.1 The United Kingdom
    • 12.1.2 Sweden
    • 12.1.3 Norway
    • 12.1.4 Baltics
    • 12.1.5 Ireland
    • 12.1.6 Rest of Northern Europe
  • 12.2 Northern Europe Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 12.2.1 Genetic Testing
    • 12.2.2 PCR
    • 12.2.3 Serological
    • 12.2.4 Antibody Screening
    • 12.2.5 Blood Typing
  • 12.3 Northern Europe Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 12.3.1 Healthcare
    • 12.3.2 Blood Donation
    • 12.3.3 Diagnostics
    • 12.3.4 Medical Research
    • 12.3.5 Transfusion
  • 12.4 Northern Europe Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 12.5 Northern Europe Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 12.6 Northern Europe Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 13 : Southern Europe Blood Screening Typing Market Breakdown by Country, Type & Application
  • 13.1 Southern Europe Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 13.1.1 Spain
    • 13.1.2 Italy
    • 13.1.3 Portugal
    • 13.1.4 Greece
    • 13.1.5 Rest of Southern Europe
  • 13.2 Southern Europe Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 13.2.1 Genetic Testing
    • 13.2.2 PCR
    • 13.2.3 Serological
    • 13.2.4 Antibody Screening
    • 13.2.5 Blood Typing
  • 13.3 Southern Europe Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 13.3.1 Healthcare
    • 13.3.2 Blood Donation
    • 13.3.3 Diagnostics
    • 13.3.4 Medical Research
    • 13.3.5 Transfusion
  • 13.4 Southern Europe Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 13.5 Southern Europe Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 13.6 Southern Europe Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 14 : East Asia Blood Screening Typing Market Breakdown by Country, Type & Application
  • 14.1 East Asia Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 14.1.1 China
    • 14.1.2 Japan
    • 14.1.3 South Korea
    • 14.1.4 Taiwan
    • 14.1.5 Others
  • 14.2 East Asia Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 14.2.1 Genetic Testing
    • 14.2.2 PCR
    • 14.2.3 Serological
    • 14.2.4 Antibody Screening
    • 14.2.5 Blood Typing
  • 14.3 East Asia Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 14.3.1 Healthcare
    • 14.3.2 Blood Donation
    • 14.3.3 Diagnostics
    • 14.3.4 Medical Research
    • 14.3.5 Transfusion
  • 14.4 East Asia Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 14.5 East Asia Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 14.6 East Asia Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 15 : Southeast Asia Blood Screening Typing Market Breakdown by Country, Type & Application
  • 15.1 Southeast Asia Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 15.1.1 Vietnam
    • 15.1.2 Singapore
    • 15.1.3 Thailand
    • 15.1.4 Malaysia
    • 15.1.5 Indonesia
    • 15.1.6 Philippines
    • 15.1.7 Rest of SEA Countries
  • 15.2 Southeast Asia Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 15.2.1 Genetic Testing
    • 15.2.2 PCR
    • 15.2.3 Serological
    • 15.2.4 Antibody Screening
    • 15.2.5 Blood Typing
  • 15.3 Southeast Asia Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 15.3.1 Healthcare
    • 15.3.2 Blood Donation
    • 15.3.3 Diagnostics
    • 15.3.4 Medical Research
    • 15.3.5 Transfusion
  • 15.4 Southeast Asia Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 15.5 Southeast Asia Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 15.6 Southeast Asia Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 16 : South Asia Blood Screening Typing Market Breakdown by Country, Type & Application
  • 16.1 South Asia Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 16.1.1 India
    • 16.1.2 Bangladesh
    • 16.1.3 Others
  • 16.2 South Asia Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 16.2.1 Genetic Testing
    • 16.2.2 PCR
    • 16.2.3 Serological
    • 16.2.4 Antibody Screening
    • 16.2.5 Blood Typing
  • 16.3 South Asia Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 16.3.1 Healthcare
    • 16.3.2 Blood Donation
    • 16.3.3 Diagnostics
    • 16.3.4 Medical Research
    • 16.3.5 Transfusion
  • 16.4 South Asia Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 16.5 South Asia Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 16.6 South Asia Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 17 : Central Asia Blood Screening Typing Market Breakdown by Country, Type & Application
  • 17.1 Central Asia Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 17.1.1 Kazakhstan
    • 17.1.2 Tajikistan
    • 17.1.3 Others
  • 17.2 Central Asia Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 17.2.1 Genetic Testing
    • 17.2.2 PCR
    • 17.2.3 Serological
    • 17.2.4 Antibody Screening
    • 17.2.5 Blood Typing
  • 17.3 Central Asia Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 17.3.1 Healthcare
    • 17.3.2 Blood Donation
    • 17.3.3 Diagnostics
    • 17.3.4 Medical Research
    • 17.3.5 Transfusion
  • 17.4 Central Asia Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 17.5 Central Asia Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 17.6 Central Asia Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 18 : Oceania Blood Screening Typing Market Breakdown by Country, Type & Application
  • 18.1 Oceania Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 18.1.1 Australia
    • 18.1.2 New Zealand
    • 18.1.3 Others
  • 18.2 Oceania Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 18.2.1 Genetic Testing
    • 18.2.2 PCR
    • 18.2.3 Serological
    • 18.2.4 Antibody Screening
    • 18.2.5 Blood Typing
  • 18.3 Oceania Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 18.3.1 Healthcare
    • 18.3.2 Blood Donation
    • 18.3.3 Diagnostics
    • 18.3.4 Medical Research
    • 18.3.5 Transfusion
  • 18.4 Oceania Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 18.5 Oceania Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 18.6 Oceania Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]
Chapter 19 : MEA Blood Screening Typing Market Breakdown by Country, Type & Application
  • 19.1 MEA Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2019-2023]
    • 19.1.1 Turkey
    • 19.1.2 South Africa
    • 19.1.3 Egypt
    • 19.1.4 UAE
    • 19.1.5 Saudi Arabia
    • 19.1.6 Israel
    • 19.1.7 Rest of MEA
  • 19.2 MEA Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2019-2023]
    • 19.2.1 Genetic Testing
    • 19.2.2 PCR
    • 19.2.3 Serological
    • 19.2.4 Antibody Screening
    • 19.2.5 Blood Typing
  • 19.3 MEA Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2019-2023]
    • 19.3.1 Healthcare
    • 19.3.2 Blood Donation
    • 19.3.3 Diagnostics
    • 19.3.4 Medical Research
    • 19.3.5 Transfusion
  • 19.4 MEA Blood Screening Typing Market by Country (USD Million) & Sales Volume (Units) [2024-2031]
  • 19.5 MEA Blood Screening Typing Market by Type (USD Million) & Sales Volume (Units) [2024-2031]
  • 19.6 MEA Blood Screening Typing Market by Application (USD Million) & Sales Volume (Units) [2024-2031]

Chapter 20: Research Findings & Conclusion
  • 20.1 Key Findings
  • 20.2 Conclusion

Chapter 21: Methodology and Data Source
  • 21.1 Research Methodology & Approach
    • 21.1.1 Research Program/Design
    • 21.1.2 Market Size Estimation
    • 21.1.3 Market Breakdown and Data Triangulation
  • 21.2 Data Source
    • 21.2.1 Secondary Sources
    • 21.2.2 Primary Sources

Chapter 22: Appendix & Disclaimer
  • 22.1 Acronyms & bibliography
  • 22.2 Disclaimer

Frequently Asked Questions (FAQ):

The Blood Screening Typing market is expected to see value worth 3Billion in 2023.

According to the report,the Blood Screening Typing Industry size is projected to reach 8Billion, exhibiting a CAGR of 22% by 2031.

Some of the prominent trends that are influencing and driving the growth of Global Blood Screening Typing Market are Healthcare, Blood Tests

  • Increasing Need For Blood Transfusion In Critical Patients

As Industry players prepare to scale up, Blood Screening Typing Market sees major concern such as Regulatory Approval, Market Competition.

Some of the opportunities that Analyst at HTF MI have identified in Blood Screening Typing Market are:
  • Increasing Healthcare Expenditure

Agena Bioscience, Inc. (United States), Beckman Coulter. (United States), Bio-Rad Laboratories, Inc. (United States), DAY MEDICAL SA. (Switzerland), Grifols, S.A. (Spain), Immucor, Inc. (United States), Merck KGaA. (Germany), Quotient, Ltd. (Switzerland), Abbott Laboratories, Inc. (United States), F. Hoffmann-La Roche Ltd. (Switzerland) etc are the main players listed in the Global Blood Screening Typing Market Study.

The Global Blood Screening Typing Market Study is Broken down by applications such as Healthcare, Blood Donation, Diagnostics, Medical Research, Transfusion.

The Global Blood Screening Typing Market Study is segmented by Genetic Testing, PCR, Serological, Antibody Screening, Blood Typing.

The Global Blood Screening Typing Market Study includes regional breakdown as North America, LATAM, West Europe,Central & Eastern Europe, Northern Europe, Southern Europe, East Asia, Southeast Asia, South Asia, Central Asia, Oceania, MEA

Historical Year: 2019 - Base year: 2023. Forecast period**: 2025 to 2031 [** unless otherwise stated]

Blood screening typing is a test that determines a person’s blood type. The test is essential if need a blood transfusion or are planning to donate blood. Not all blood types are compatible, so it’s important to know blood group. Receiving blood that’s incompatible with blood type could trigger a dangerous immune response. Blood screening typing is done prior to a blood transfusion or when classifying a person’s blood for donation. Blood typing is a fast and easy way to ensure that receive the right kind of blood during surgery or after an injury. Blood screening typing is especially important for pregnant women.
-->